PRIOR INFORMATION NOTICE: Antibacterial and antimycobacterial products for systemic use

Finnish Institute for Health and Welfare, later referred to as THL or Customer, is about to publish a call for tenders for antibacterial and antimycobacterial products for systemic use. The date of publication of the call for tenders is planned for October 2024. The scope of procurement is described in …

CPV: 33651000 Antiinfecciosos generales para uso sistémico, vacunas, 33600000 Productos farmacéuticos, 33651100 Antibacterianos para uso sistémico, 33651300 Antimicobacterianos
Lugar de ejecución:
PRIOR INFORMATION NOTICE: Antibacterial and antimycobacterial products for systemic use
Organismo adjudicador:
Finnish Institute for Health and Welfare
Número de premio:
THL/5372/2.02.06/2024

1. Buyer

1.1 Buyer

Official name : Finnish Institute for Health and Welfare
Legal type of the buyer : Central government authority
Activity of the contracting authority : Health

2. Procedure

2.1 Procedure

Title : PRIOR INFORMATION NOTICE: Antibacterial and antimycobacterial products for systemic use
Description : Finnish Institute for Health and Welfare, later referred to as THL or Customer, is about to publish a call for tenders for antibacterial and antimycobacterial products for systemic use. The date of publication of the call for tenders is planned for October 2024. The scope of procurement is described in more detail in Annex 1. The procurement will be divided in twelve (12) lots. Each product constitutes a separate lot. Tender may be submitted for one or several lots. - LOT 1: Moxifloxacin 400 mg / 250 ml (250 ml, i.v. solution, ATC J01MA14) - LOT 2: Linezolid 2 mg/ml (300 ml, i.v. solution, ATC J01XX08) - LOT 3: Linezolid 600 mg (tablet/capsule, oral, ATC J01XX08) - LOT 4: Pyrazinamide 500 mg (tablet/capsule, oral, ATC J04AK01) - LOT 5: Etambuthol 500 mg (tablet/capsule, oral, ATC J04AK02) - LOT 6: Clindamycin 300 mg (tablet/capsule, oral, ATC J01FF01) - LOT 7: Isoniazide 300 mg (tablet/capsule, oral, ATC J04AC01) - LOT 8: Claritromycin 250 mg (tablet/capsule, oral, ATC J01FA09) - LOT 9: Clindamycin 15 mg/ml (80 ml, oral suspension, ATC J01FF01) - LOT 10: Moxifloxacin 400 mg (tablet/capsule, oral, ATC J01MA14) - LOT 11: Levofloxacin 500 mg (tablet/capsule, oral, ATC J01MA12) - LOT 12: Claritromycin oral suspension 50 mg/ml (50 ml, oral suspension ATC J01FA09) The minimum requirements for the products is described in Annex 1.1. The contract will be awarded to one supplier for each lot based on a comparison of tenders. Estimated quantity for the products is described in Annex 1.2 (restricted to security classification level IV, TL IV). In addition to the estimated quantity indicated in the Annex 1.2, the Customer is entitled to purchase 100 % extra to the estimated quantities (later referred as "Option"). The supplier is not obliged to deliver the products under the Option. THL reserves the right to change the scope of the procurement and the minimum requirements in the published call for tenders.
Internal identifier : THL/5372/2.02.06/2024

2.1.1 Purpose

Main nature of the contract : Supplies
Main classification ( cpv ): 33651000 General anti-infectives for systemic use and vaccines
Additional classification ( cpv ): 33600000 Pharmaceutical products
Additional classification ( cpv ): 33651100 Antibacterials for systemic use
Additional classification ( cpv ): 33651300 Antimycobacterials

2.1.2 Place of performance

Country : Finland
Anywhere in the given country

2.1.4 General information

Additional information : The availability for the Annex 1.2 is restricted to security classification level IV (TL IV). THL will send the Annex 1.2 to a representative of the tenderer via encrypted e-mail after THL has received a scanned version of the signed confidentiality commitment (Annex 2). The signature of the confidentiality commitment shall be done manually by hand. Confidentiality commitment shall be signed by a legal representative of tenderer. Confidentiality commitment shall be sent to the e-mail address kirjaamo@thl.fi with the subject line: "CONFIDENTIALITY COMMITMENT - THL/5372/2.02.06/2024 / Antibacterial and antimycobacterial products for systemic use". The message shall contain name of the tenderer and e-mail address to which the Annex 1.2 is to be sent.
Legal basis :
Directive 2014/24/EU

3. Part

3.1 Part technical ID : PAR-0000

Title : PRIOR INFORMATION NOTICE: Antibacterial and antimycobacterial products for systemic use
Description : Finnish Institute for Health and Welfare, later referred to as THL or Customer, is about to publish a call for tenders for antibacterial and antimycobacterial products for systemic use. The date of publication of the call for tenders is planned for October 2024. The scope of procurement is described in more detail in Annex 1. The procurement will be divided in twelve (12) lots. Each product constitutes a separate lot. Tender may be submitted for one or several lots. - LOT 1: Moxifloxacin 400 mg / 250 ml (250 ml, i.v. solution, ATC J01MA14) - LOT 2: Linezolid 2 mg/ml (300 ml, i.v. solution, ATC J01XX08) - LOT 3: Linezolid 600 mg (tablet/capsule, oral, ATC J01XX08) - LOT 4: Pyrazinamide 500 mg (tablet/capsule, oral, ATC J04AK01) - LOT 5: Etambuthol 500 mg (tablet/capsule, oral, ATC J04AK02) - LOT 6: Clindamycin 300 mg (tablet/capsule, oral, ATC J01FF01) - LOT 7: Isoniazide 300 mg (tablet/capsule, oral, ATC J04AC01) - LOT 8: Claritromycin 250 mg (tablet/capsule, oral, ATC J01FA09) - LOT 9: Clindamycin 15 mg/ml (80 ml, oral suspension, ATC J01FF01) - LOT 10: Moxifloxacin 400 mg (tablet/capsule, oral, ATC J01MA14) - LOT 11: Levofloxacin 500 mg (tablet/capsule, oral, ATC J01MA12) - LOT 12: Claritromycin oral suspension 50 mg/ml (50 ml, oral suspension ATC J01FA09) The minimum requirements for the products is described in Annex 1.1. The contract will be awarded to one supplier for each lot based on a comparison of tenders. Estimated quantity for the products is described in Annex 1.2 (restricted to security classification level IV, TL IV). In addition to the estimated quantity indicated in the Annex 1.2, the Customer is entitled to purchase 100 % extra to the estimated quantities (later referred as "Option"). The supplier is not obliged to deliver the products under the Option. THL reserves the right to change the scope of the procurement and the minimum requirements in the published call for tenders.
Internal identifier : 755394

3.1.1 Purpose

Main nature of the contract : Supplies
Main classification ( cpv ): 33651000 General anti-infectives for systemic use and vaccines
Additional classification ( cpv ): 33600000 Pharmaceutical products
Additional classification ( cpv ): 33651100 Antibacterials for systemic use
Additional classification ( cpv ): 33651300 Antimycobacterials

3.1.2 Place of performance

Country : Finland
Anywhere in the given country

3.1.5 General information

Reserved participation :
The procurement is covered by the Government Procurement Agreement (GPA) : yes
Additional information : The availability for the Annex 1.2 is restricted to security classification level IV (TL IV). THL will send the Annex 1.2 to a representative of the tenderer via encrypted e-mail after THL has received a scanned version of the signed confidentiality commitment (Annex 2). The signature of the confidentiality commitment shall be done manually by hand. Confidentiality commitment shall be signed by a legal representative of tenderer. Confidentiality commitment shall be sent to the e-mail address kirjaamo@thl.fi with the subject line: "CONFIDENTIALITY COMMITMENT - THL/5372/2.02.06/2024 / Antibacterial and antimycobacterial products for systemic use". The message shall contain name of the tenderer and e-mail address to which the Annex 1.2 is to be sent.

3.1.6 Procurement documents

Access to certain procurement documents is restricted
Justification for restricting access to certain procurement documents : Protection of particularly sensitive information
Languages in which the procurement documents are officially available : English
Information about restricted documents is available at : https://tarjouspalvelu.fi/thl?id=524745&tpk=a2ea05d3-6a17-4e90-98c9-c6b9b8bd4565 ,

3.1.9 Further information, mediation and review

Review organisation : Markkinaoikeus

8. Organisations

8.1 ORG-0001

Official name : Finnish Institute for Health and Welfare
Registration number : 2229500-6
Postal address : PL 30
Town : Helsinki
Postcode : 00271
Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Contact point : Procurement services / Keskitetty hankintatoimi
Telephone : +358 295246000
Internet address : http://www.thl.fi/
Roles of this organisation :
Buyer

8.1 ORG-0002

Official name : Markkinaoikeus
Registration number : 3006157-6
Postal address : Radanrakentajantie 5
Town : Helsinki
Postcode : 00520
Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Telephone : +358 295643300
Roles of this organisation :
Review organisation

8.1 ORG-0003

Official name : Hansel Oy (Hilma)
Registration number : FI09880841
Postal address : Mannerheiminaukio 1a
Town : Helsinki
Postcode : 00100
Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Contact point : eSender
Telephone : 029 55 636 30
Roles of this organisation :
TED eSender

11. Notice information

11.1 Notice information

Notice identifier/version : a9593a7f-70b7-4980-849b-fa21dd77d51e - 01
Form type : Planning
Notice type : Prior information notice or a periodic indicative notice used only for information
Notice dispatch date : 04/09/2024 07:08 +00:00
Notice dispatch date (eSender) : 04/09/2024 07:24 +00:00
Languages in which this notice is officially available : English

11.2 Publication information

Notice publication number : 00533018-2024
OJ S issue number : 173/2024
Publication date : 05/09/2024
Estimated date of publication of a contract notice within this procedure : 01/10/2024